I found that Whitman's collegial environment, fostered by supportive faculty, administrators, and fellow students, encouraged me to get involved and to try to make a difference. As a result, I learned firsthand how rewarding it can be to take a chance on pursuing something you believe in, whether you ultimately succeed or fail. My willingness to take risks, nurtured during my years at Whitman, has served me well throughout my professional career.
Scott Greer, '81
R. Scott Greer, '81, has been president, CEO, and director of Abgenix, a California biophar-maceutical company, since 1996. Last year he became chairman of the board, and he also serves as director of CV Therapeutics and Thuris Corporation. Abgenix is a leader in developing antibody-based therapeutic products for treatment of a variety of disease conditions including cancer, transplant-related diseases, autoimmune disorders, and others. In 2000, Greer was selected as the Ernst & Young Entrepreneur of the Year in the Life Sciences category for the Bay Area.
Greer, whose M.B.A. is from Harvard, worked for Genetics Institute, Inc., a biotechnology company, from 1986 to 1991, holding various positions including director of corporate development. He joined Cell Genesys, serving as chief financial officer and vice president of corporate development from 1991 to 1993 and senior vice president of corporate development from 1994 to 1996.